ShareValue scores for 002252.SHE: Valuation 66, Quality 45, Growth 29, Health 35.

002252.SHE
SZSE

Shanghai RAAS Blood Products Co Ltd Class A

CN¥5.04(+2.86%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

3% to 17%
Valuation
66
Fair Value
Price vs Value
Quality
45
Moderate
Business Strength
Growth
29
Weak
Revenue & Earnings
Health
35
Stressed
Financial Stability
Momentum
24
Bearish
Price Trend

Company Details

About

Shanghai RAAS Blood Products Co., Ltd., together with its subsidiaries, produces and sells blood products in China and internationally. The company offers ALBURAAS, which is albumin prepared from human plasma; GAMARAAS, a human immunoglobulin product for intravenous injections; HEMORAAS, a human coagulation factor VIII product; PROTHORAAS, a human prothrombin complex; FIBRORAAS, a human fibrinogen; FIBINGLURAAS, a fibrin sealant for humans; and THROMBIRAAS, a human thrombin product. It also provides specific immune, human tetanus immunoglobulin, human rabies immunoglobulin, human immunoglobulin, hepatitis B human immunoglobulin, and other blood products. The company exports its products. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is headquartered in Shanghai, China. Address: No. 2009, Wangyuan Road, Shanghai, China, 201401

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026